Welcome to our dedicated page for Archimedes Tech Spac Ptnrs Iii SEC filings (Ticker: ARCIU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Archimedes Tech Spac Ptnrs Iii's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Archimedes Tech Spac Ptnrs Iii's regulatory disclosures and financial reporting.
Archimedes Tech SPAC Partners III Co. is allowing investors to trade its ordinary shares and warrants separately from its units. Each unit currently trades on Nasdaq under the symbol ARCIU and consists of one ordinary share and one-fourth of one redeemable warrant.
Beginning on or about March 16, 2026, holders of units sold in the company’s IPO may elect to separate them so that the ordinary shares trade under ARCI and the whole warrants trade under ARCIW. Units that are not separated will continue to trade under ARCIU, and holders must work through their brokers and the transfer agent, Odyssey Transfer and Trust Company, to complete any separation.
Archimedes Tech SPAC Partners III Co. completed its initial public offering of 27,600,000 units at $10.00 each, raising gross proceeds of $276,000,000. Each unit includes one ordinary share and one-quarter of a warrant exercisable at $11.50 per share.
The sponsor and BTIG bought 762,000 private units for $7,620,000, bringing total cash in the trust account to $276,000,000 as of January 26, 2026. The audited balance sheet shows current cash outside the trust of $1,267,360, total assets of $277,516,995 and a shareholders’ deficit driven by $276,000,000 of ordinary shares classified as redeemable.
The SPAC has 24 months from the IPO closing to complete a business combination, or it must return trust funds (plus interest, less permitted amounts) to public shareholders. A total of 7,090,500 warrants are outstanding, and founders hold 6,900,000 locked-up founder shares aligned to 20% of post-IPO ordinary shares.
Archimedes Tech SPAC Partners III Co. is offering $240,000,000 through the sale of 24,000,000 units at $10.00 per unit. Each unit consists of one ordinary share and one-fourth of one warrant; whole warrants exercisable at $11.50 per share under the stated terms.
The prospectus states proceeds (including private units) of $246,900,000 and that $240,000,000 will be deposited in a U.S.-based trust account. The company is a Cayman Islands blank check company with a 24-month completion window to consummate an initial business combination, subject to permitted extensions and shareholder approval.